المؤلفون: Marta Bilik, Steve Vucic, Waldemar Brola, Monica Badve, Grzegorz Kozera, Joseph Kwan, David Werring, Erik Lundström, Anna Czlonkowska, Paul Bentley, Graeme Hankey, Alastair Buchan, David Doig, Christian Lueck, Maurizio BALESTRINO, Urszula Fiszer, Richard Lindley, Geoffrey Cloud, Francesco Corea, Karl Matz, Cathie Sudlow, Joana Damásio, Rui Felgueiras, Andrea Zini, William Whiteley, Stefan Engelter, Malcolm Robert Macleod, Luana Benedetti, Joanna Wardlaw, Peter Sandercock, Bartosz Karaszewski, Hedley Emsley, Jan Aaseth, Leo Bonati, Marta Leńska-Mieciek, Mark Wardle, Marc Randall, Antonio Arauz

المساهمون: UCL - SSS/IONS/NEUR - Clinical Neuroscience, UCL - (SLuc) Service de neurologie

المصدر: Trials
Trials, Vol 12, Iss 1, p 252 (2011)
Trials, Vol. 12, p. 252 [1-9] (2011)
Sandercock, P, Lindley, R, Wardlaw, J, Dennis, M, Innes, K, Cohen, G, Whiteley, W, Perry, D, Soosay, V, Buchanan, D, Venables, G, Czlonkowska, A, Kobayashi, A, Berge, E, Slot, K B, Murray, V, Peeters, A, Hankey, G J, Matz, K, Brainin, M, Ricci, S, Cantisani, T A, Gubitz, G, Phillips, S J, Arauz, A, Correia, M, Lyrer, P, Kane, I, Lundstrom, E, Lewis, S & Ist-3 Collaborative Group, O B O T 2011, ' Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited ', Trials, vol. 12, no. 1, pp. 252 . https://doi.org/10.1186/1745-6215-12-252

مصطلحات موضوعية: Neurology, medicine.medical_treatment, Medicine (miscellaneous), Research & Experimental Medicine, Tissue plasminogen activator, law.invention, Brain Ischemia, 0302 clinical medicine, Randomized controlled trial, law, Brain Ischemia drug therapy, Data monitoring committee, Pharmacology (medical), Thrombolytic Therapy, 030212 general & internal medicine, Prospective Studies, Prospective cohort study, Stroke, 1102 Cardiorespiratory Medicine and Haematology, lcsh:R5-920, Thrombolysis, 3. Good health, Medicine, Research & Experimental, Tissue Plasminogen Activator, Acute Disease, lcsh:Medicine (General), Life Sciences & Biomedicine, medicine.drug, medicine.medical_specialty, Double-Blind Method, Fibrinolytic Agents, Humans, Sample Size, Stroke drug therapy, Update, 03 medical and health sciences, ALTEPLASE, Double-Blind Method, Fibrinolytic Agents, IST-3 collaborative group, General & Internal Medicine, medicine, Science & Technology, business.industry, 1103 Clinical Sciences, medicine.disease, Cardiovascular System & Hematology, Emergency medicine, Physical therapy, business, 030217 neurology & neurosurgery, Fibrinolytic agent

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10598009036e51240e3ffe0bf9484ee9
http://europepmc.org/articles/PMC3286387

المؤلفون: André Peeters, Maria Grazia Celani, Martin Dennis, Karsten Bruins Slot, Steve Phillips, Veronica Murray, Antonio Arauz, Teresa Anna Cantisani, Enrico Righetti, Steff Lewis, Karl Matz, Gord Gubitz, Graham Venables, Manuel Correia, Joanna M. Wardlaw, Graeme J. Hankey, Eivind Berge, Anna Członkowska, Stefano Ricci, Richard I. Lindley, Peter Sandercock, Adam Kobayashi, Michael Brainin, Kameshwar Prasad, P. A. Lyrer

المصدر: Trials
Trials, Vol 9, Iss 1, p 37 (2008)
Sandercock, P, Lindley, R, Wardlaw, J, Dennis, M, Lewis, S, Venables, G, Kobayashi, A, Czlonkowska, A, Berge, E, Slot, K B, Murray, V, Peeters, A, Hankey, G, Matz, K, Brainin, M, Ricci, S, Celani, M G, Righetti, E, Cantisani, T, Gubitz, G, Phillips, S, Arauz, A, Prasad, K & Correia, M & Lyrer, P 2008, ' The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke ', Trials, vol. 9, 37, pp.-. https://doi.org/10.1186/1745-6215-9-37

مصطلحات موضوعية: medicine.medical_specialty, Pathology, ECASS, medicine.medical_treatment, Medicine (miscellaneous), BLOOD-PRESSURE, Tissue plasminogen activator, THERAPY, SIMPLE QUESTIONS, law.invention, 03 medical and health sciences, Study Protocol, 0302 clinical medicine, Randomized controlled trial, ALTEPLASE, law, Internal medicine, Ischaemic stroke, medicine, MANAGEMENT, Pharmacology (medical), 030212 general & internal medicine, Symptom onset, Recombinant tissue plasminogen activator, Stroke, TISSUE-PLASMINOGEN ACTIVATOR, lcsh:R5-920, HYPERTENSION, business.industry, Thrombolysis, RANDOMIZED CONTROLLED-TRIAL, medicine.disease, 3. Good health, ATLANTIS, Blood pressure, Cardiology, business, lcsh:Medicine (General), 030217 neurology & neurosurgery, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62468c7ff47b14717445cb4df4aa0ee4
http://europepmc.org/articles/PMC2442584

المؤلفون: Marquez-Romero, Juan Manuel, Arauz, Antonio, Ruiz-Sandoval, José Luis, de la Cruz-Estrada, Erick, Huerta-Franco, Maria Raquel, Aguayo-Leytte, Gerónimo, Ruiz-Franco, Angélica, Silos, Humberto

المصدر: Trials; 2013, Vol. 14 Issue 1, p1-7, 7p, 1 Diagram, 1 Chart

مصطلحات موضوعية: HEMORRHAGE, STROKE, INTRACEREBRAL hematoma, CEREBRAL hemorrhage, CLINICAL trials